Cargando…

P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma

Detalles Bibliográficos
Autores principales: Lohmann, Mia, Buchberger, Iris, Beielstein, Anna, Kaçar, Başak, Mattlener, Julia, Nill, Marieke, Shi, Zhiyuan, Heger, Jan-Michel, Pallasch, Christian, Ullrich, Roland, Borchmann, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621541/
http://dx.doi.org/10.1097/01.HS9.0000890752.16913.40
_version_ 1784821580987105280
author Lohmann, Mia
Buchberger, Iris
Beielstein, Anna
Kaçar, Başak
Mattlener, Julia
Nill, Marieke
Shi, Zhiyuan
Heger, Jan-Michel
Pallasch, Christian
Ullrich, Roland
Borchmann, Sven
author_facet Lohmann, Mia
Buchberger, Iris
Beielstein, Anna
Kaçar, Başak
Mattlener, Julia
Nill, Marieke
Shi, Zhiyuan
Heger, Jan-Michel
Pallasch, Christian
Ullrich, Roland
Borchmann, Sven
author_sort Lohmann, Mia
collection PubMed
description
format Online
Article
Text
id pubmed-9621541
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96215412022-11-01 P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma Lohmann, Mia Buchberger, Iris Beielstein, Anna Kaçar, Başak Mattlener, Julia Nill, Marieke Shi, Zhiyuan Heger, Jan-Michel Pallasch, Christian Ullrich, Roland Borchmann, Sven Hemasphere Genomics, Biology & Microenvironment Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621541/ http://dx.doi.org/10.1097/01.HS9.0000890752.16913.40 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Genomics, Biology & Microenvironment
Lohmann, Mia
Buchberger, Iris
Beielstein, Anna
Kaçar, Başak
Mattlener, Julia
Nill, Marieke
Shi, Zhiyuan
Heger, Jan-Michel
Pallasch, Christian
Ullrich, Roland
Borchmann, Sven
P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
title P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
title_full P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
title_fullStr P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
title_full_unstemmed P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
title_short P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
title_sort p046: preclinical evaluation of novel repurposed drug combinations in hodgkin lymphoma
topic Genomics, Biology & Microenvironment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621541/
http://dx.doi.org/10.1097/01.HS9.0000890752.16913.40
work_keys_str_mv AT lohmannmia p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT buchbergeriris p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT beielsteinanna p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT kacarbasak p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT mattlenerjulia p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT nillmarieke p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT shizhiyuan p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT hegerjanmichel p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT pallaschchristian p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT ullrichroland p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma
AT borchmannsven p046preclinicalevaluationofnovelrepurposeddrugcombinationsinhodgkinlymphoma